Enzalutamide in metastatic prostate cancer before chemotherapy

N Engl J Med. 2014 Oct 30;371(18):1755-6. doi: 10.1056/NEJMc1410239.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Androgen Receptor Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Humans
  • Male
  • Phenylthiohydantoin / analogs & derivatives*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Receptor Antagonists
  • Antineoplastic Agents, Hormonal
  • Phenylthiohydantoin